BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2004
View Archived Issues
Therapeutic benefits of recombinant PSA vaccines in advanced prostate cancer
Read More
Pulmicort HFA-MDI completes phase III
Read More
CDC recommends resumption of third Prevnar dose
Read More
Positive data, revised phase III plans for naveglitazar
Read More
BresaGen completes U.S. merger with Cythera
Read More
Positive phase II results for Allox
Read More
Abbott plans Xinlay NDA filing later this year
Read More
New phase II trial for M-40403
Read More
Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma
Read More
Second subgroup in Sinovac SARS vaccine phase I trials receives inoculations
Read More
MS-325 in new post-NDA program
Read More
Phase IIb study evaluates Reverset in HIV patients failing therapy
Read More
Tacrolimus results presented at pediatric dermatology congress
Read More
Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth
Read More
Zafirlukast induces symptomatic response in women with recurrent VVC
Read More
Clinical evidence for the efficacy of pregabalin in painful diabetic neuropathy
Read More
Salbutamol reported to improve muscle strength in children with congenital myopathies
Read More
Benzoxazinone derivatives for the treatment of CNS and other disorders
Read More
Selective angiotensin AT2 receptor agonists described by Vicore Pharma
Read More
Nonsteroidal modulators of farnesoid X receptors described in patent literature
Read More
Takeda patent claims compounds that inhibit somatostatin receptor binding
Read More
Inhibitors of receptor tyrosine kinases claimed by Array BioPharma
Read More
CRF1 receptor antagonists for anxiety, affective disorders, etc.
Read More
Good safety and acceptability profile found with Carraguard in HIV-positive patients
Read More